Effects of growth hormone treatment in children with cystic fibrosis: the National Cooperative Growth Study experience (Q73583051)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9255232%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Effects of growth hormone treatment in children with cystic fibrosis: the National Cooperative Growth Study experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9255232%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

D S Hardin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9255232%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J P Sy

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9255232%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9255232%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9255232%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9255232%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9255232%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

S65-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9255232%20AND%20SRC:MED&resulttype=core&format=json

Diabetes mellitus associated with cystic fibrosis

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

Relative underweight in cystic fibrosis and its prognostic value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

The growth of children with chronic paediatric disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

GROWTH PATTERNS IN CHILDREN WITH CYSTIC FIBROSIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

The adolescent growth spurt in children with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

Nutritional Rehabilitation in Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

Norethandrolone in cystic fibrosis of the pancreas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parenteral nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

Insulin resistance is associated with decreased clinical status in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

Effect of exogenous growth hormone on glucose utilization in burn patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970015-5

10.1016/S0022-3476(97)70015-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9255232%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference